Full-Time
Commercial Finance Administrator
Updated on 9/3/2026
Inizio Engage
501-1,000 employees
Provides integrated data insights for pharma
No salary listed
Ashby-de-la-Zouch, UK
Hybrid
At least two days per week in the Ashby-de-la-Zouch office; the remaining two to three days may be worked remotely. Applicants must live within a one-hour commute.
 Accounting (1) |
|---|
Get referred to Inizio Engage
See people who can refer or advise you
- Previous experience working in a finance administration role.
- No previous experience with Procim or Oracle is required.
- Comfort working with multiple stakeholders.
- A focus on accuracy and consistency, with a dedication to high levels of customer service.
- Intermediate-level Microsoft Excel skills, including the ability to review complex spreadsheets, and proficiency with the Microsoft Office 365 package.
- The ability to work on clear tasks unsupervised.
- Good communication skills and self-motivation.
- Residence within a commutable distance of the Ashby-de-la-Zouch office, defined as within one hour.
- Manage the Commercial Finance inbox by answering and resolving queries.
- Manage an integrated system error queue.
- Refresh daily reports.
- Refresh weekly forecast reports.
- Cross-check data and update systems accurately.
- Send project status emails to project owners.
- Support the Commercial Finance Partner with job closures, including reconciling Procim data such as time and purchase orders.
- Move time and costs between projects.
- Maintain users and personnel within Procim.
- Check reports and flag outstanding finance actions.
- Send communications regarding project status and tracking, and update centralised reports with responses.
- Attend weekly team meetings.
- Provide general support to the Commercial Finance team with administrative tasks and actions.
- A professional and helpful demeanour.
- A can-do approach to team working.
Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Dublin Township, Pennsylvania
Founded
N/A
Get referred to Inizio Engage
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2026 Connected Insights expands APAC medical information and adds speech analytics, virtual agents.
- April 2026 Hub Services launch strengthens patient access programs at Asembia, a major industry venue.
- September 2026 events calendar shows active marketing at PIPA, Fierce Pharma Week, and expopharm.
What critics are saying
- Inizio's AI tools commoditize skilled service labor, pressuring pricing when pharma buyers benchmark automation in 2027.
- Revelio estimated 332 active job postings in 2026, down 102.4 percent from 2025.
- If major clients internalize patient support, Engage loses scale fast.
What makes Inizio Engage unique
- Inizio Engage runs 6,000 experts across 20+ countries, giving local execution at global scale.
- Its April 2026 Hub Services unify access, reimbursement, pharmacy, and adherence in one platform.
- Connected Insights turns one million scientific interactions into medical-information intelligence and AI-enabled workflows.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Private Medical Insurance
Life Insurance
Pension Scheme
Hybrid Work Options
Paid Vacation
401(k) Retirement Plan
Company News
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50
We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.
Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.
After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.
Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.